Twist Bioscience (TWST) Other Working Capital Changes (2017 - 2026)

Twist Bioscience (TWST) has reported Other Working Capital Changes for 10 consecutive years, with $11.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 1081.99% year-over-year to $11.1 million; the TTM figure through Mar 2026 stood at $23.5 million (up 1491.58% YoY), while the FY2025 annual figure was $3.7 million, up 1073.04% from the prior year.
• Other Working Capital Changes rose to $11.1 million in Q1 2026 per TWST's latest filing, from $7.7 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $11.1 million in Q1 2026 and bottomed at -$1.1 million in Q1 2025.
• Historically, Other Working Capital Changes has averaged $1.7 million across 5 years, with a median of $1.1 million in 2023.
• Annual changes were most pronounced in 2024 — Other Working Capital Changes plunged 268.12% — and 2025, when it jumped 3006.43%.
• Twist Bioscience's Other Working Capital Changes stood at $1.2 million in 2022, then dropped by 5.18% to $1.1 million in 2023, then plunged by 77.69% to $249000.0 in 2024, then surged by 3006.43% to $7.7 million in 2025, then jumped by 43.84% to $11.1 million in 2026.
• Business Quant data shows TWST's Other Working Capital Changes at $11.1 million in Q1 2026, $7.7 million in Q4 2025, and $1.9 million in Q3 2025.